Rodney Whitlock, managing director, and Rick Van Buren, senior principal of Cozen O’Connor Public Strategies’ federal health policy practice, were quoted in STAT News on incoming Democrats’ plans to investigate the Trump administration’s most-favored-nation drug pricing agreements. Rodney said he doubts Democrats and the administration will find common ground on the agreements and Medicare drug price negotiation. Rick expects Democrats to investigate the deals but doubts they will negotiate legislation with the administration.